Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades

Objective The aim of this study was to compare the clinical presentation and incidence of postmolar gestational trophoblastic neoplasia (GTN) among cases of complete mole (CM) and partial mole (PM) from 1994 to 2013. Methods This study included all cases of patients with CM and PM from our trophoblastic disease center between 1994 and 2013. Their clinical and pathologic reports were reviewed. Gestational age at evacuation, features of clinical presentation, human chorionic gonadotropin levels, and the rate of progression to GTN were compared. Results The median gestational age at evacuation was 9 weeks for CM and 12 weeks for PM (P < 0.001). Patients with PM had lower pre-evacuation serum human chorionic gonadotropin levels (P < 0.001), and they were also less likely to present with vaginal bleeding (P < 0.001), biochemical hyperthyroidism (P < 0.001), anemia (P < 0.001), uterine size greater than dates (P < 0.001), and hyperemesis (P = 0.002). Consequently, patients with PM were less likely to have been clinically diagnosed as moles compared with CM prior to uterine evacuation (P < 0.001). The development of GTN occurred in 17.7% (33/186) and 4.1% (7/169) of patients with CM and PM, respectively (P < 0.001). Conclusions This study indicates that, at our center over the past 20 years, both CM and PM were usually evacuated in the first trimester of pregnancy. Because CM more commonly presents with the signs and symptoms of molar disease than PM, CM is more commonly diagnosed prior to evacuation.

[1]  R. Berkowitz,et al.  Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? , 2015, Gynecologic oncology.

[2]  Jae-Weon Kim,et al.  Trophoblastic Disease Review for Diagnosis and Management: A Joint Report From the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup , 2014, International Journal of Gynecologic Cancer.

[3]  N. Sebire,et al.  Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit , 2014, Journal of Clinical Pathology.

[4]  L. Magee,et al.  The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. , 2014, Pregnancy hypertension.

[5]  L. Marions,et al.  Current clinical features of complete and partial hydatidiform mole in Sweden. , 2014, The Journal of reproductive medicine.

[6]  A. Shiozaki,et al.  A triploid partial mole placenta from paternal isodisomy with a diploid fetus derived from one sperm and one oocyte may have caused angiogenic imbalance leading to preeclampsia-like symptoms at 19 weeks of gestation. , 2013, Placenta.

[7]  K. Kagan,et al.  ISUOG Practice Guidelines: performance of first‐trimester fetal ultrasound scan , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  Suwicha Chittithaworn,et al.  Complete Hydatidiform Mole: Change in Clinical Profile over Three Decades , 2012 .

[9]  J. Lurain Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. , 2010, American journal of obstetrics and gynecology.

[10]  L. Say,et al.  Maternal near miss--towards a standard tool for monitoring quality of maternal health care. , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[11]  R. Berkowitz,et al.  Molar pregnancy: pathology and management , 2008 .

[12]  O. Gemer,et al.  Reduction of postmolar gestational trophoblastic neoplasia by early diagnosis and treatment. , 2009, The Journal of reproductive medicine.

[13]  F. Sweep,et al.  Earlier Diagnosis and Serum Human Chorionic Gonadotropin Regression in Complete Hydatidiform Moles , 2009, Obstetrics and gynecology.

[14]  R. Berkowitz,et al.  Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. , 2006, The Journal of reproductive medicine.

[15]  B. Hancock,et al.  Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. , 2006, The Journal of reproductive medicine.

[16]  N. Tanaka,et al.  Changes in the incidence of molar pregnancies. A population-based study in Chiba Prefecture and Japan between 1974 and 2000. , 2003, Human reproduction.

[17]  FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[18]  R. Mclellan,et al.  Gestational trophoblastic disease. , 2001, Obstetrics and gynecology clinics of North America.

[19]  E. Jauniaux,et al.  Partial moles: from postnatal to prenatal diagnosis. , 1999, Placenta.

[20]  R. Berkowitz,et al.  Complete molar pregnancy. Clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia. , 1998, The Journal of reproductive medicine.

[21]  R. Berkowitz,et al.  Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. , 1998, The Journal of reproductive medicine.

[22]  E. Newlands,et al.  A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non‐molar hydropic abortions , 1996, Histopathology.

[23]  R. Berkowitz,et al.  The Changing Clinical Presentation of Complete Molar Pregnancy , 1995, Obstetrics and gynecology.

[24]  E. Kohorn Natural history of partial molar pregnancy. , 1986, Obstetrics and gynecology.

[25]  U. Surti,et al.  The Clinicopathologic Profile of the Partial Hydatidiform Mole , 1982, Obstetrics and gynecology.

[26]  M. Lancet,et al.  Partial Moles: A Clinicopathologic Study of 25 Cases , 1982, Obstetrics and gynecology.

[27]  E. Beutner,et al.  Report of a WHO Scientific Group (Part 3 of 3) , 1973 .

[28]  Nutritional anaemias. Report of a WHO scientific group. , 1968, World Health Organization technical report series.